<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01884298</url>
  </required_header>
  <id_info>
    <org_study_id>EPIISO-021</org_study_id>
    <nct_id>NCT01884298</nct_id>
  </id_info>
  <brief_title>Effect of Different Anesthetic Techniques for Isolated Systolic Hypertensive Patients of Abdominal Surgery on Postoperative Hospital Stay and Morbidity</brief_title>
  <official_title>Effect of Different Anesthetic Techniques for Isolated Systolic Hypertensive Patients of Abdominal Surgery on Postoperative Hospital Stay and morbidity---a Prospective, Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In General anesthesia, two main ways of pain control are used intra-operatively, one is
      opioids, the other is epidural. Many colleges prefer using epidural analgesia because it is
      potent and more effective , and also the benefits of stress block, less depression of breath.
      however, the epidural technique often causes more drop of blood pressure, especially in
      dehydrated patients. The investigators designed the trial to see if the benefit weigh out the
      potential risk of epidural in isolated hypertensive patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of postoperative hospital stay</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiovascular morbidity</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>respiratory morbidity</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative renal failure</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>patients with isolated systolic hypertension</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients combined with isolated systolic hypertension undergoing abdominal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil(Ultiva)</intervention_name>
    <description>remifentanil (TCI, Ce 3 ng /ml)for intra-operative analgesia</description>
    <arm_group_label>patients with isolated systolic hypertension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epidural infusing 2% lidocaine</intervention_name>
    <description>epidural infusing 2% lidocaine 4ml bolus followed by 6-18ml/hr for intra-operative analgesia</description>
    <arm_group_label>patients with isolated systolic hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - adults aged 50-70 with isolated systolic hypertension .

        Exclusion Criteria:

          -  age &lt; 50 yr, ASA grade IV, severe cardiac or pulmonary insufficiency (FEV1 &lt; 1 litre)
             , malignant hypertension, psychiatric illness (intake of psychiatric medication other
             than selective serotonin re-uptake inhibitors), diastolic blood pressure more than 110
             mmHg. emergency surgery, coagulopathy, significant renal and hepatic dysfunction
             (creatinine &gt; 50% or liver enzymes &gt; 50% upper limit of normal values)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongxin Wang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>PKU 1st hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PKU 1st hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2013</study_first_submitted>
  <study_first_submitted_qc>June 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>June 21, 2013</last_update_submitted>
  <last_update_submitted_qc>June 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>ZhouYan</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>remifentanil</keyword>
  <keyword>isolated systolic hypertension</keyword>
  <keyword>morbidity</keyword>
  <keyword>epidural combined general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

